Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Stem Cell Culture01:17

Stem Cell Culture

5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Claudio Bordignon.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

The inflammatory "death-to-life" loop in VEXAS syndrome.

Blood·2026
Same author

Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters.

Nature biotechnology·2026
Same author

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial.

Nature medicine·2026
Same author

VEXAS syndrome.

Nature reviews. Disease primers·2026
Same author

Editorial: Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy.

Frontiers in immunology·2026

関連する実験動画

Updated: Jul 21, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

482

生体内幹細胞工学への一歩

Samuele Ferrari1, Luigi Naldini1,2

  • 1San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele, Milan, Italy.

Science (New York, N.Y.)
|July 27, 2023
PubMed
まとめ

メッセンジャーRNA (mRNA) 配送は,血液形成幹細胞遺伝子治療に革命をもたらす可能性を秘めています. この革新的なアプローチは 血液幹細胞に影響する遺伝的疾患の 現在の治療パラダイムを 大きく変える可能性があります

科学分野:

  • * 血液学と遺伝子療法
  • * 分子生物学と薬物投与

背景:

  • * 血造性幹細胞 (HSC) 遺伝子治療は,遺伝的な血液疾患の治療法として有望である.
  • * 現在の遺伝子治療法は,効率と安全性に問題があります.

研究 の 目的:

  • * HSCにおける遺伝子配送のためのメッセンジャーRNA (mRNA) の可能性を調査する.
  • * mRNAをHSC遺伝子療法における変革的アプローチとして評価する.

主な方法:

  • HSC の mRNA ベースの配送システムを調査しています.
  • * この新しい遺伝子転送方法の有効性と実現可能性を評価する.

主要な成果:

  • * mRNA配送は,HSC遺伝子治療を改変する可能性があることを示しています.
  • * このアプローチは,既存の遺伝子療法の限界を克服する可能性がある.

結論:

  • * mRNAベースの投与は,HSC遺伝子治療のパラダイムシフトを表しています.
  • * この分野におけるmRNAの治療的可能性を完全に実現するために,さらなる研究が必要である.

さらに関連する動画

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.1K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.9K

関連する実験動画

Last Updated: Jul 21, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

482
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.1K
Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

8.9K